This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cell Therapeutics' CEO Hosts Annual Shareholder Meeting (Transcript)

Stocks in this article: CTIC

I will cover each of the proposals in more detail and there will be an opportunity for shareholder questions on the proposals following the presentation of the proposals and before voting on the proposals take place. Following a vote on proposals of the shareholders, we will conclude the business portion of the meeting.

We have available for inspection a list of all shareholders as of the record date and proof of due calling of the meeting. In addition, I have received an oath signed by Mr. Christensen, the Inspector of Election which is available for your examination and will be filed within minutes of this meeting stating that he will faithfully execute with strict and partiality, his duty as Inspector of Election.

I have been informed by the Inspector of Election that we have a quorum of votes represented in person or by proxy for the meeting. Accordingly, I declare that a quorum is present, the meeting is properly constituted and convened for the purpose of transacting such business as may properly come before.

The first order of business to be discussed is the election of directors. We have three nominees for directors. If elected these directors will serve until the 2015 Annual Meeting of shareholders. All nominees are currently members of our Board of Directors.

The nominees are Richard L. Love, Dr Mary Mundinger, and Dr. Jack Singer. Do I hear a motion for the election of the individuals to our Board of Directors to serve until our 2015 annual meeting of shareholders.

Do I hear a second? A motion to elect these nominees has been made and seconded. As there is no discussion, we will proceed to vote. Second matter to be considered is the proposal to approve an increase in the number of shares of our authorized stock from 384,999,999 shares to 751,666,666 shares and an increase in the number of shares of our common stock authorized for issuance from 383,333,333 shares to 750 million.

2 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs